Seeking Alpha

Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options

ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...
WFMZ-TV

Global Spinal Cord Stimulation (SCS) Market 2019-2023: Rise in Adoption of Surgical Robots / Proclaim XR / 7D Surgical System / Attempts by Major Players to Strengthen Presence ...

DUBLIN, Dec. 9, 2019 /PRNewswire/ -- The "Global Spinal Cord Stimulation (SCS) Market: Size, Trends & Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering. Global Spinal ...
BioWorld

FDA approves Abbott's spinal cord stimulator for non-surgical back pain

Abbott Laboratories received U.S. FDA approval for an expanded indication for its spinal cord stimulator (SCS) devices to include treatment of chronic back pain for individuals who have not had or are ...
Monthly Prescribing Reference

Abbott’s SCS Systems Approved for Nonsurgical Refractory Back Pain

Credit: Shutterstock. Study participants suffered from chronic back pain for an average of 12.8 years. The Food and Drug Administration (FDA) has expanded the approval of Abbott’s spinal cord ...
Kaleido Scope

Dudeja accepted into Society of Clinical Surgery

Vikas Dudeja, M.D., FACS, James P. Hayes, Jr., Endowed Professor in Gastrointestinal Oncology and Director of the Division of Surgical Oncology, has been accepted into the Society of Clinical Surgery ...